# A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

> **NCT07754175** · — · RECRUITING · sponsor: **Kang Stem Biotech Co., Ltd.** · enrollment: 36 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07754175
- **Lead sponsor:** Kang Stem Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-20
- **Primary completion:** 2031-12-31
- **Final completion:** 2032-02-28
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07754175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07754175, "A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07754175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*